相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A New Carbon Nanotube-Based Breast Cancer Drug Delivery System: Preparation and In Vitro Analysis Using Paclitaxel
Wei Shao et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Effective Photothermal Chemotherapy Using Doxorubicin-Loaded Gold Nanospheres That Target EphB4 Receptors in Tumors
Jian You et al.
CANCER RESEARCH (2012)
General Route to Multifunctional Uniform Yolk/Mesoporous Silica Shell Nanocapsules: A Platform for Simultaneous Cancer-Targeted Imaging and Magnetically Guided Drug Delivery
Lingyu Zhang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Mesoporous Multifunctional Upconversion Luminescent and Magnetic Nanorattle Materials for Targeted Chemotherapy
Fan Zhang et al.
NANO LETTERS (2012)
Squalene Based Nanocomposites: A New Platform for the Design of Multifunctional Pharmaceutical Theragnostics
Jose L. Arias et al.
ACS NANO (2011)
Anti-Estrogen-Loaded Superparamagnetic Liposomes for Intracellular Magnetic Targeting and Treatment of Breast Cancer Tumors
Vincent Plassat et al.
ADVANCED FUNCTIONAL MATERIALS (2011)
The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas
Mu-Yi Hua et al.
BIOMATERIALS (2011)
Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas
Hung-Wei Yang et al.
BIOMATERIALS (2011)
Engineering Nanocomposite Materials for Cancer Therapy
Caterina Minelli et al.
SMALL (2010)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Biofunctionalized targeted nanoparticles for therapeutic applications
Andrew Z. Wang et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1
Dan Peer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform
Seungpyo Hong et al.
CHEMISTRY & BIOLOGY (2007)
Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging
Marianne Manchester et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems
Norased Nasongkla et al.
NANO LETTERS (2006)
Pegylated liposomal doxorubicin in the treatment of cancers of the breast and ovary
Maurie Markman
EXPERT OPINION ON PHARMACOTHERAPY (2006)
Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
M. R. Green et al.
ANNALS OF ONCOLOGY (2006)
Nanotechnology: Intelligent design to treat complex disease
Patrick Couvreur et al.
PHARMACEUTICAL RESEARCH (2006)
A folate receptor-targeted liposomal formulation for paclitaxel
Jun Wu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Fluoxetine and reversal of multidrug resistance
Dan Peer et al.
CANCER LETTERS (2006)
Nanocarriers: Promising vehicle for bioactive drugs
Manju Rawat et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Polymer conjugates as anticancer nanomedicines
Ruth Duncan
NATURE REVIEWS CANCER (2006)
Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies
DW Nyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
WJ Gradishar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Liposomal encapsulated anti-cancer drugs
RD Hofheinz et al.
ANTI-CANCER DRUGS (2005)
Bevacizurnab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer
HI Hurwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cancer nanotechnology: Opportunities and challenges
M Ferrari
NATURE REVIEWS CANCER (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Nanomedicines for overcoming biological barriers
MJ Alonso
BIOMEDICINE & PHARMACOTHERAPY (2004)
Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
P Sabbatini et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
TY Kim et al.
CLINICAL CANCER RESEARCH (2004)
Targeted therapies for cancer 2004
JS Ross et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Amphiphilic block copolymers for drug delivery
ML Adams et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
The dawning era of polymer therapeutics
R Duncan
NATURE REVIEWS DRUG DISCOVERY (2003)
Synthesis and in vivo antitumor activity of poly(L-glutamic acid) conjugates of 20(S)-camptothecin
RL Bhatt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Ligand-targeted therapeutics in anticancer therapy
TM Allen
NATURE REVIEWS CANCER (2002)
Poly(L-glutamic acid) - anticancer drug conjugates
C Li
ADVANCED DRUG DELIVERY REVIEWS (2002)
Phase IV study of liposomal daunorubicin (DaunoXome) in AIDS-related Kaposi sarcoma
E Rosenthal et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
Development of the polymer micelle carrier system for doxorubicin
T Nakanishi et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Pegylation - A novel process for modifying pharmacokinetics
JM Harris et al.
CLINICAL PHARMACOKINETICS (2001)
分享论文
